DK1581644T3 - Oprensning af polypeptider - Google Patents

Oprensning af polypeptider

Info

Publication number
DK1581644T3
DK1581644T3 DK04700878T DK04700878T DK1581644T3 DK 1581644 T3 DK1581644 T3 DK 1581644T3 DK 04700878 T DK04700878 T DK 04700878T DK 04700878 T DK04700878 T DK 04700878T DK 1581644 T3 DK1581644 T3 DK 1581644T3
Authority
DK
Denmark
Prior art keywords
homogenate
broth
polypeptide
lactate
polypeptides
Prior art date
Application number
DK04700878T
Other languages
Danish (da)
English (en)
Inventor
Philip M Lester
Josefine Persson
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK1581644T3 publication Critical patent/DK1581644T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK04700878T 2003-01-09 2004-01-08 Oprensning af polypeptider DK1581644T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43941803P 2003-01-09 2003-01-09
PCT/US2004/000499 WO2004092393A1 (en) 2003-01-09 2004-01-08 Purification of polypeptides

Publications (1)

Publication Number Publication Date
DK1581644T3 true DK1581644T3 (da) 2007-10-08

Family

ID=33299572

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04700878T DK1581644T3 (da) 2003-01-09 2004-01-08 Oprensning af polypeptider

Country Status (18)

Country Link
US (2) US7169908B2 (enExample)
EP (1) EP1581644B1 (enExample)
JP (1) JP2006517415A (enExample)
KR (1) KR20050095605A (enExample)
CN (1) CN100467611C (enExample)
AT (1) ATE364092T1 (enExample)
AU (1) AU2004230670B2 (enExample)
BR (1) BRPI0406470A (enExample)
CA (1) CA2511946A1 (enExample)
DE (1) DE602004006831T2 (enExample)
DK (1) DK1581644T3 (enExample)
ES (1) ES2287687T3 (enExample)
MX (1) MXPA05007378A (enExample)
NZ (1) NZ540895A (enExample)
PL (1) PL377653A1 (enExample)
RU (1) RU2337968C2 (enExample)
WO (1) WO2004092393A1 (enExample)
ZA (1) ZA200504990B (enExample)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE498409T1 (de) 1998-08-06 2011-03-15 Mountain View Pharmaceuticals Peg-uricase konjugate und verwendung davon
HUE027196T2 (hu) * 2002-09-06 2016-10-28 Genentech Inc Eljárás fehérjeextrakcióra
US9534013B2 (en) * 2006-04-12 2017-01-03 Horizon Pharma Rheumatology Llc Purification of proteins with cationic surfactant
TWI418564B (zh) * 2005-04-11 2013-12-11 Savient Pharmaceuticals Inc 利用陽離子界面活性劑之蛋白質純化
NZ562292A (en) 2005-04-11 2009-11-27 Savient Pharmaceuticals Inc Variant forms of urate oxidase and use thereof
EP1973942B1 (en) 2005-12-22 2011-02-09 Genentech, Inc. Recombinant production of heparin binding proteins
FR2902799B1 (fr) 2006-06-27 2012-10-26 Millipore Corp Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
NZ573639A (en) 2006-07-14 2012-03-30 Genentech Inc Refolding of recombinant proteins
US8362217B2 (en) 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
WO2008079302A2 (en) 2006-12-21 2008-07-03 Millipore Corporation Purification of proteins
DK2104739T3 (da) * 2006-12-21 2013-10-07 Novozymes Inc Modificerede messenger-RNA-stabiliseringssekvenser til ekspression af gener i bakterieceller
US8569464B2 (en) 2006-12-21 2013-10-29 Emd Millipore Corporation Purification of proteins
AU2008209404B2 (en) * 2007-01-22 2012-08-16 Genentech, Inc. Polyelectrolyte precipitation and purification of antibodies
PL2188302T3 (pl) 2007-07-09 2018-04-30 Genentech, Inc. Zapobieganie redukcji wiązań disiarczkowych podczas rekombinacyjnego wytwarzania polipeptydów
US7887821B2 (en) * 2007-12-20 2011-02-15 Alk-Abello A/S Process for producing an allergen extract
WO2009151514A1 (en) 2008-06-11 2009-12-17 Millipore Corporation Stirred tank bioreactor
GB0818228D0 (en) * 2008-10-06 2008-11-12 Avecia Biolog Ltd Purification process
EP2337787A1 (en) * 2008-10-17 2011-06-29 Percivia LLC. Clarification process
US20100190963A1 (en) 2008-12-16 2010-07-29 Millipore Corporation Stirred Tank Reactor And Method
KR101861547B1 (ko) 2009-06-25 2018-07-02 크레알타 파마슈티칼스 엘엘씨 페길화된 유리카아제 치료 중에 혈청 요산을 모니터링하여 주입 반응의 위험성 및 반응의 항체­매개 상실을 예측하는 방법 및 키트
KR101858598B1 (ko) * 2010-02-01 2018-05-16 디그나 비오테크, 에스.엘. 인터페론 알파 5의 제조방법
ES2395093T3 (es) * 2010-02-12 2014-12-22 Laboratorios Leti, S.L. Proceso para producir un extracto de alérgenos
EP2545066B1 (en) * 2010-03-10 2017-09-20 F. Hoffmann-La Roche AG Method for purifying immunoglobulin solutions
JO3131B1 (ar) 2010-04-27 2017-09-20 Glaxosmithkline Llc مركبات كيميائية
EP2571903B1 (en) 2010-05-17 2019-09-04 EMD Millipore Corporation Stimulus responsive polymers for the purification of biomolecules
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
DE102011001743A1 (de) * 2011-04-01 2012-10-04 Technische Universität Dortmund Verfahren zur Trennung/Reinigung von Biomolekühlen
KR102492792B1 (ko) 2011-10-11 2023-01-30 제넨테크, 인크. 이중특이적 항체의 개선된 어셈블리
CN102443055B (zh) * 2011-10-26 2017-07-28 浙江海正药业股份有限公司 一种重组人肿瘤坏死因子相关凋亡诱导配体的纯化工艺
WO2013180648A1 (en) * 2012-05-31 2013-12-05 Agency For Science, Technology And Research Methods for use of mixed multifunctional surfaces for reducing aggregate content in protein preparations
CN102701501A (zh) * 2012-06-26 2012-10-03 天津市津华盛生物科技有限公司 工业乳酸链球菌素废水综合利用的方法
CN105026418B (zh) * 2013-02-06 2019-01-11 新加坡科技研究局 蛋白质纯化方法
EP2961759A4 (en) 2013-02-26 2016-09-28 Agency Science Tech & Res PROTEIN CLEANING IN THE PRESENCE OF NON-ORGANIC POLYMERS AND ELECTROPOSITIVE SURFACES
CN105189530B (zh) * 2013-02-28 2019-06-07 新加坡科技研究局 从缺乏染色质的细胞培养收获物中色谱纯化抗体
WO2014133460A1 (en) * 2013-02-28 2014-09-04 Agency For Science, Technology And Research Protein purification in the presence of nonionic organic polymers at elevated conductivity
EP2992021B1 (en) * 2013-04-30 2020-07-22 Intas Pharmaceuticals Limited Novel cloning, expression & purification method for the preparation of ranibizumab
RU2687153C2 (ru) * 2014-04-30 2019-05-07 Новозимс А/С Способ снижения содержания днк в ферментационном бульоне
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
EP3538135A4 (en) 2016-11-11 2020-07-29 Horizon Pharma Rheumatology LLC POLYTHERAPIES OF PREDNISONE AND URICASE MOLECULES AND THEIR USES
CN108333263A (zh) * 2017-01-20 2018-07-27 北京蛋白质组研究中心 一种尿蛋白制备方法及尿蛋白质组的检测方法
TW201927335A (zh) * 2017-10-02 2019-07-16 美商拜耳保健有限責任公司 防止雙硫鍵於細胞培養收集物中還原之方法
BR112020010615A2 (pt) * 2017-12-22 2020-10-27 Regeneron Pharmaceuticals, Inc. produto farmacêutico proteico, método e sistema para caracterizar impurezas de produto farmacêutico proteico e de fármaco de baixo peso molecular, método para produzir um anticorpo, anticorpo, e, usos do método e do sistema
CN111363024A (zh) * 2018-12-26 2020-07-03 深圳翰宇药业股份有限公司 多肽的纯化方法
WO2020247983A1 (en) * 2019-06-05 2020-12-10 Viome, Inc. Sample collection methods and devices
EP4136211B1 (en) 2020-04-15 2025-07-09 Genentech, Inc. Copper loss mitigation
CN112708566A (zh) * 2021-01-25 2021-04-27 西南林业大学 一种黑曲霉生产胞外多聚物的优化培养基及培养方法
CN114774500A (zh) * 2022-04-26 2022-07-22 成都蜀星饲料有限公司 多肽及制备方法、有机复合微量元素及制备方法
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL34079A (en) * 1969-04-01 1973-02-28 Upjohn Co Purification of ypsilon-globulins
US3607857A (en) * 1970-03-03 1971-09-21 Upjohn Co Process of removing acrinol from gamma globulin using siliceous material such as silica gel
US3903254A (en) * 1971-07-23 1975-09-02 Upjohn Co Separation of erythrocyte stroma from lysing medium and hemoglobin with acrinol
DE2308013A1 (de) * 1973-02-17 1974-09-12 Behringwerke Ag Katalasearme glucoseoxidase und verfahren zu ihrer gewinnung
JPS519035B2 (enExample) 1973-10-31 1976-03-23
SU944580A1 (ru) 1980-02-07 1982-07-23 Кировский научно-исследовательский институт переливания крови Способ получени поверхностного антигена гепатита В
US4563303A (en) * 1984-04-14 1986-01-07 Judicial Foundation The Chemosero-Therapeutic Research Institute Method for purification of filamentous hemagglutinin
JPS60258127A (ja) * 1984-06-04 1985-12-20 Green Cross Corp:The B型肝炎ワクチンの製造方法
WO1986007093A1 (fr) * 1985-05-29 1986-12-04 The Green Cross Corporation Procede de preparation d'une proteine heterogene
WO1987000553A1 (fr) * 1985-07-16 1987-01-29 The Green Cross Corporation Procede de preparation d'hetero-proteine
DE3604947A1 (de) 1986-02-17 1987-08-20 Biotest Pharma Gmbh Verfahren zur herstellung eines immunglobulinhaltigen praeparates und dessen verwendung zur prophylaxe und therapie von aids
FR2600078B1 (fr) 1986-06-12 1989-07-13 Merieux Inst Procede de preparation de facteur xiii a partir du placenta
DE3929504A1 (de) * 1989-09-06 1991-03-07 Behringwerke Ag Verfahren zur reinigung von plasminogen-aktivator-inhibitor 2 (pai-2)
DE4030264A1 (de) * 1990-09-25 1992-04-23 Hoechst Ag Verfahren zur herstellung gereinigter glycolipide durch membrantrennverfahren
GB9215540D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
US5861263A (en) * 1992-10-20 1999-01-19 Universidad Autonoma De Nuevo Leon Preparation of preserved entamoeba histolytica antigens without enzymatic inhibitors and their use in immunological methods
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5760189A (en) 1995-06-02 1998-06-02 Genetics Institute, Inc. Protein recovery & purification methods
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
DK0998486T4 (da) 1997-06-13 2012-05-14 Genentech Inc Proteinoprensning ved kromatografi efterfulgt af filtrering på en ladet fase
JPH11341947A (ja) * 1998-06-02 1999-12-14 Yakult Honsha Co Ltd 発酵管理方法
US6156514A (en) * 1998-12-03 2000-12-05 Sunol Molecular Corporation Methods for making recombinant cells
AU2001231016A1 (en) * 2000-01-20 2001-07-31 Regents Of The University Of Minnesota Peptides with antibacterial activity

Also Published As

Publication number Publication date
BRPI0406470A (pt) 2005-12-06
US7169908B2 (en) 2007-01-30
AU2004230670B2 (en) 2010-11-25
ATE364092T1 (de) 2007-06-15
EP1581644B1 (en) 2007-06-06
NZ540895A (en) 2007-03-30
DE602004006831D1 (de) 2007-07-19
EP1581644A1 (en) 2005-10-05
US20070077625A1 (en) 2007-04-05
DE602004006831T2 (de) 2008-02-14
ZA200504990B (en) 2006-08-30
JP2006517415A (ja) 2006-07-27
CN1759186A (zh) 2006-04-12
RU2005125210A (ru) 2006-01-10
CA2511946A1 (en) 2004-10-28
PL377653A1 (pl) 2006-02-06
MXPA05007378A (es) 2005-11-23
US20050037456A1 (en) 2005-02-17
RU2337968C2 (ru) 2008-11-10
AU2004230670A1 (en) 2004-10-28
ES2287687T3 (es) 2007-12-16
KR20050095605A (ko) 2005-09-29
CN100467611C (zh) 2009-03-11
WO2004092393A1 (en) 2004-10-28
US7579448B2 (en) 2009-08-25

Similar Documents

Publication Publication Date Title
DK1581644T3 (da) Oprensning af polypeptider
EP1236754A3 (en) Polyhydroxyalkanoate and method of producing same, and omega-(2-thienylsulfanyl) alkanoic acid and method of producing same
SI1428878T1 (sl) Postopek za proizvodnjo in čiščenje eritropoietina
ATE414162T1 (de) Verfahren und materialien zur herstellung von glucosamin
BR0108711A (pt) Expressão heteróloga de proteìnas de neisseria
DK1697523T3 (da) Ekspressionsvektor til antibiotikafri ekspression
RU2002111335A (ru) Среда для культивирования клеток без белков и без сыворотки
PL376381A1 (en) Methods and media for controlling sialylation of proteins produced by mammalian cells
ATE454463T1 (de) Überexpression von extremozymgenen in pseudomonas und nahe verwandte bakterien
KR840002031A (ko) Dna, 재조합 dna, 이들을 갖는 숙주 및 폴리펩타이드를 제조하는 방법
ATE484591T1 (de) Minimale dna sequenz, die als chromatin-isolator wirkt, und deren verwendung für die protein- expression
WO2000056903A3 (en) IMPROVED METHODS FOR PRODUCING PROTEINS IN TRANSFORMED $i(PICHIA)
BR9810650A (pt) Vetor para expressão de proteìna heteróloga e métodos para extrair proteìna recombinante e para purificar insulina recombinante isolada
ATE357458T1 (de) Signalsequenzen zur herstellung von leu-hirudin über sekretion durch e. coli in das kulturmedium
EP1277831A3 (de) Verfahren und Vorrichtung zur Ernte mikrobieller Biomasse aus einem Kultivationssystem
WO2003057720A3 (en) Recovery of biofilament proteins from biological fluids
DE60219361D1 (de) Verfahren zur rekombinanten herstellung von plazenta wachstumsfaktor
ATE420161T1 (de) Monopropylenglykol als fermentationszusatz
ATE393166T1 (de) Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen
SE9904247D0 (sv) Compositions and methods utilizing sequences for controlling nucleic acid expression in yeast
ATE346921T1 (de) Menschliches, durch kalzium aktivierbares kaliumkanalpolypeptid aus leukozyten
ATE412616T1 (de) Bakterienstamm zur entfernung der gesamten gelösten feststoffe von gerbereiabwasser
WO2008024311A3 (en) Purification of low-abundant recombinant proteins from cell culture
MA27744A1 (fr) Procedes permettant d'empecher la glyconoylation de proteines
ATE390481T1 (de) Modifizierte tridegine, ihre herstellung und verwendung als transglutaminase-inhibitoren